• leader board size
Consumer Research2020-11-05T23:41:25-08:00

Consumer Research

Week In Review: Cannabis & Psychedelics Industry Highlights

LOS ANGELES - Critical compliance issues, market exits, and clinical and regulatory breakthroughs shaped a turbulent week for cannabis and psychedelics businesses. Cannabis Industry Highlights 1.Cresco Labs Exits California, Refocuses on Profitability Cresco Labs confirmed ...

Health Canada Approves Jazz Pharmaceuticals’ Epidiolex

NEW YORK- Canada's federal health regulator, Health Canada, has recently approved Epidiolex, a cannabinoid-based medicine developed by Jazz Pharmaceuticals Canada. This approval positions Epidiolex as a supplementary therapy for certain rare and severe forms of ...

Arkansas and Rhode Island Cannabis Markets

LOS ANGELES- October 2023 witnessed a modest reduction in medical cannabis sales in Arkansas, reaching $22.5 million, a slight decrease from the same period in 2022. This data, sourced from the state's Department of Finance ...

Algernon Pharmaceuticals Partners with Seyltx Inc.

LOS ANGELES- Algernon Pharmaceuticals Inc., a Canadian clinical stage pharmaceutical development company, has announced a significant advancement in its research program. The company has signed a Letter of Intent (LOI) with Seyltx Inc., a U.S.-based ...

Optimi Health Obtains Key Amendment to Dealer’s Licence

LOS ANGELES- Optimi Health, a Canadian company specializing in psychedelic drug research and formulation, has achieved a significant milestone with Health Canada's approval of an amendment to its Dealer's Licence. This crucial development allows Optimi ...

Subscribe To Our Newsletter

Go to Top